AtlantiCare President and CEO Lori Herndon has informed the health system’s Board of Trustees that she intends to retire on June 30 following an exemplary 40-year career that began as a nurse and earned her respect and esteem far beyond New Jersey.
“As many of you know, I began my career as a critical care nurse and enjoyed every opportunity to learn and grow over 40 years at AtlantiCare,” Herndon said in a note to team members. “I care deeply about our AtlantiCare team, our patients and our community. Our impact on the community and our patients we serve has been immeasurable and I will always be proud of working with our AtlantiCare team through some of healthcare’s most challenging times.”
The Board expressed gratitude for her consistent dedication to AtlantiCare and the people it serves. Board Chairman David Goddard will work closely with AtlantiCare’s executive leadership team to assure a smooth transition during the search for a new CEO.
“Lori’s impact on AtlantiCare and her leadership in the hospital has been far-reaching. She has provided steady and solid leadership through the unprecedented challenges of the COVID-19 pandemic while expanding clinical services and programs in our region,” Goddard said.
Herndon joined AtlantiCare as a critical care staff nurse in 1983 and served as a hospital administrator and chief operating officer before becoming president and CEO in 2016. She has been the face of AtlantiCare in the health system’s South Jersey service area and beyond and played an integral role in supporting staff through the pandemic.
Herndon recently had the honor of being named as one of Modern Healthcare’s 100 most influential leaders in healthcare. She also recently completed a year’s tenure as president of the New Jersey Hospital Association, where she introduced the Consider Kindness campaign focused on recognizing and supporting healthcare providers. She will transition her CEO responsibilities on May 31 and work with the Board and leadership team as needed to support the transition until her retirement on June 30.
The board will seek a new CEO who can build upon AtlantiCare’s success as an independent health system and assure that it continues to thrive in an evolving and highly competitive market, Goddard said. The board will consider any qualified candidates from both inside and outside AtlantiCare for the CEO position. Patients and AtlantiCare team members should not notice any change during the transition.
“AtlantiCare has a strong and seasoned executive leadership team, and dedicated team members across the organization, to ensure a smooth transition to a new CEO with the right vision for our health system and the communities we serve,” Goddard said. “We will seek a new leader to define and execute our strategic priorities for the future, with the same commitment to personalized health, healing and wellness services that people expect from AtlantiCare.”